Carlumab

DB12718ApprovedWithdrawnProtein Based Therapies

Carlumab has been used in trials studying the treatment of Cancer and Prostate Cancer.

Mechanism: Pharmacologically active on C-C motif chemokine 2
Curator reviewed
Also known as: Human monoclonal antibody targeting CC-chemokine ligand 2 (CNTO 888)
Code names: CNTO-888

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Carlumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.